source
- Experts highlight unmet needs and emerging role of antibody drug conjugates in endometrial cancerExperts note that significant unmet needs persist in endometrial cancer even as antibody drug conjugates (ADCs) begin to expand treatment options. They suggest ADCs could address gaps in recurrent…
- Experts discuss emerging therapies shaping the future of relapsed and refractory multiple myelomaIn a recent opinion segment, Dr. Ajay Nooka and Dr. Noopur Raje explore how new treatments and ongoing trials are influencing the landscape for patients with relapsed and refractory multiple myelom…